FORWARD FEATURES CALENDAR

Find us on

Latest News

Runway Growth Capital (Runway), a provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, global private investment firm Skyview Capital (Skyview), have made a significant growth investment in Fidelis Cybersecurity (Fidelis).  The investment will provide working capital to enable Fidelis’ continued success in developing cyber solutions that help security teams from top commercial, enterprise, and government agencies worldwide find and stop threats faster and more effectively.  Fidelis is a specialist n Active eXtended Detection and Response (XDR) solutions that are trusted by Fortune 100 firms and government organisations worldwide. The company’s proactive
VCP Apex, a global provider of financial, advisory, and capital raising services for corporate and fund manager clients, announces today three strategic hires in its New York and Hong Kong offices, as it continues to strengthen its global capabilities. Jill Cohen joined in July as Managing Director and Head of the Americas, from Mercury Capital where she was a Partner. She has over 20 years of experience within the alternative asset management industry, having held senior positions at several firms, including Avenue Capital, Salient Partners, and MPM Capital. She was also head of Capital Introduction for the Americas at Citigroup.
Tikehau Capital has partnered with iCapital, a global fintech platform providing access and to alternative investments for the asset and wealth management industries, to increase wealth managers’ access to Tikehau’s private market investing opportunities. Through the partnership, Tikehau Capital will launch a customised marketplace powered by iCapital’s technology to deliver Tikehau Capital’s suite of alternative offerings to wealth managers and their high-net-worth clients in the EMEA region.   Initially, the digital solution will provide wealth managers with access to alternative investments which are generally accessible to institutional investors only. It includes the second vintage of Tikehau Capital’s Impact-driven real estate
ECI Partners, a growth-focused mid-market private equity firm, has added to its commercial team with the appointment of Mia Smith as an associate. Smith is ECI’s sixth new hire in the last 12 months, representing a 20% increase in investment professionals.   ECI’s Commercial Team works with portfolio companies, offering hands-on-support to management teams from day one of ECI’s investment. Smith will be supporting management teams across all these key focus areas.     Prior to joining ECI, Smith spent four years at OC&C Strategy Consultants, where she worked on a range of customer due diligence and growth strategy projects.
Funds managed by global investment firm Carlyle have acquired ManTech International Corporation (ManTech), a provider of technologies and solutions for national security programmes, in an all-cash transaction representing a total enterprise value of approximately $4.2 billion. Under the terms of the go-private transaction, ManTech stockholders will receive $96.00 per share in cash. With the completion of the transaction, ManTech’s common stock has ceased trading and will no longer be listed on the NASDAQ Global Select Market. ManTech will remain headquartered in Herndon, Virginia and the transition is expected to be seamless for customers and employees across ManTech’s business.
Tridek-One SAS, a biotech start-up specialised in the research and development of CD31 agonists to restore the immune balance, has closed a €16 million ($16.1m) financing round led by the Swiss VC Pureos Bioventures. New investors Bpifrance, through its InnoBio2 fund, and Bioqube Ventures (Belgium), as well as historical investors AdBio partners and Advent Life Sciences also participated in the round.  The funds will primarily be used to identify development candidates against auto-immune diseases, to conduct IND-enabling studies and to further build the organisation. The company previously raised €3 million ($3.02 million) in a first round in 2019 involving AdBio
Global technology investor, EV Private Equity (EV), has announced the promotions of Espen Strøm and Tomas Hvamb from partner to senior partner. Strøm will continue to lead EV’s efforts related to origination, while Hvamb will continue to head up the firm’s stewardship efforts. For over a decade at EV, both professionals have specialised in high-profile transactions, portfolio growth strategies, and exit planning.   Over the past 20 years, EV Private Equity has become established as a leading technology-enabled impact investor, committed to driving decarbonisation deep within the energy sector by shaping world-class technology companies.
Moonfare, a private equity investment platform, has surpassed $150 million in assets under management from US investors, and now offers access to private equity with minimums as low as $75k, down significantly from the previous $125k minimum. 
KKR is providing individual investors with tokenised access to a portion of one of its private equity funds through a tie-up with digital assets specialist Securitise, according to a report by the Wall Street Journal. The offering, for the second vintage of KKR’s HealthCare Strategic Growth Fund, is available to clients with at least $5 million in investable assets via the Avalanche public blockchain. The report cites an unnamed source as saying that the tokenised position in the fund is the first ever from a major equity fund in the US. Under the terms of the offering, investors will be
Latticework Capital Management (LCM), a Dallas-based private equity firm focused exclusively on healthcare control investments in the lower middle market, has formed American Clinical Research Services Holdings (ACRS) following its acquisition of the Catalina Research Institute (CRI). Financial terms of the transaction have not been disclosed. CRI is an independent clinical trials centre focussed on  high complexity trials across non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, diabetes and other metabolic diseases as well as central nervous system. The acquisition of CRI by ACRS is the first of what is expected to be multiple investments in the broader site management organisation (SMO)

Special Reports

Featured

Events

12 November, 2026 – 8:00 am

Directory Listings